COMMUNIQUÉS West-GlobeNewswire

Cambrex Invests in New Small Scale Capacity at Its Charles City, Iowa Facility
08/11/2017
EAST RUTHERFORD, NJ, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM ), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that it [...]
Skyline Medical Announces Two Proposed Joint Ventures and New Strategic Focus on CRO Services
08/11/2017
MINNEAPOLIS, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc . (NASDAQ: SKLN ) (“Skyline” or the “Company”), producer of the FDA-approved STREAMWAY ® System for automated, direct-to-drain medical fluid disposal, [...]
Lipocine Announces Financial and Operational Results for the Third Quarter and Nine Months Ended September 30, 2017
08/11/2017
SALT LAKE CITY, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Lipocine Inc. (NASDAQ: LPCN ), a specialty pharmaceutical company, today announced financial results for the three and nine months ended September 30, 2017. Third [...]
American Health Council Names Adam G. Despres, BSN, RN to Nursing Board
08/11/2017
NEW YORK, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Adam G. Despres, Registered Nurse at Hackettstown Regional Medical Center has been selected to join the Nursing Board at the American Health Council. He will be sharing his [...]
Proteon Therapeutics to Present at the Stifel 2017 Healthcare Conference November 15th
08/11/2017
WALTHAM, Mass., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq: PRTO ), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney and vascular [...]
Mesa Labs Acquires Sterilization and Disinfection Process Control Business
08/11/2017
LAKEWOOD, Colo., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB ) (we, us, our, “Mesa” or the “Company”) today announced the acquisition of substantially all of the assets and certain [...]
Jounce Therapeutics to Announce Third Quarter 2017 Financial Results and Host Conference Call on Monday, November 13, 2017
08/11/2017
CAMBRIDGE, Mass., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE ), a clinical stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers [...]
BioSig Technologies to Speak at Digital Silver Forum in Helsinki, Finland on November 28
08/11/2017
Santa Monica, CA, Nov. 08, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet [...]
Biotricity CEO and Advisory Board Member to Speak at Major Health Tech Conferences
08/11/2017
REDWOOD CITY, Calif., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB : BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring [...]
Optinose to Present at Jefferies 2017 London Healthcare Conference
08/11/2017
YARDLEY, Pa., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Optinose (NASDAQ: OPTN ), a pharmaceutical company focused on patients treated by ENT and allergy specialists, today announced that Chief Executive Officer Peter Miller [...]
Momenta Pharmaceuticals to Webcast Presentation at the Stifel 2017 Healthcare Conference
08/11/2017
CAMBRIDGE, Mass., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA ), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it [...]
Neothetics Provides Business Update and Reports Third Quarter 2017 Financial Results
08/11/2017
SAN DIEGO, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ: NEOT ) provided a business update and reported financial results for the third quarter 2017. Third Quarter 2017 and Recent Corporate Highlights In [...]
Poseida Therapeutics to Present anti-PSMA CAR-T Preclinical Data at the Society for Immunotherapy of Cancer (SITC) 32nd Annual Meeting
08/11/2017
SAN DIEGO, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc. (“Poseida”), a San Diego-based company translating best-in-class gene therapy technologies into lifesaving cell therapies, today announced that [...]
Imaging for Women Now Offering iCAD’s PowerLook® Tomo Detection for Digital Breast Tomosynthesis
08/11/2017
Technology utilizes advanced artificial intelligence to improve speed and accuracy in the detection of breast cancer KANSAS CITY, Mo., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Imaging for Women, a leading radiology center in [...]
AMAG Announces Autologous Cord Blood Cells Improve Motor Function in Some Children with Cerebral Palsy
08/11/2017
WALTHAM, Mass., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Cord Blood Registry (CBR) from AMAG Pharmaceuticals (Nasdaq: AMAG ) today announced research recently published in the journal Stem Cells Translational Medicine found [...]
Microbot Medical Inc. Receives Additional Government Grant for Development of its Self-Cleaning Shunt
08/11/2017
HINGHAM, Mass., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT ), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, has [...]
Nuvus.io Building the New Global Exchange for Cannabis Industry with Distributed ledger/Blockchain Platform Nuvus Protocol – An Irrefutable Chain of Custody Audit for the Seed to Patient using Private & Public Blockchains
08/11/2017
Saint Petersburg, FL, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Nuvus.io, a division of Nuvus Corp, is a decentralized blockchain company formed to build big data and supply chain verification ecosystem using distributive [...]
Avadel Pharmaceuticals Reports Third Quarter 2017 Results
08/11/2017
Total Revenues for the Third Quarter Were $39.7 Million Full Year Revenue Guidance of $165-$175 Million Unchanged Acquired License for Noctiva ™ DUBLIN, Ireland, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals [...]
Intra-Cellular Therapies Reports Third Quarter 2017 Financial Results and Provides Corporate Update
08/11/2017
NEW YORK, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (NASDAQ: ITCI ), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]

Pages